David A. Cory - Jul 29, 2021 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
President and CEO, Director
Signature
/s/ Sriram Ryali, Attorney-in-Fact
Stock symbol
EIGR
Transactions as of
Jul 29, 2021
Transactions value $
$0
Form type
4
Date filed
7/30/2021, 04:29 PM
Next filing
Mar 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EIGR Stock Option (Right to Buy) Award $0 +48.8K $0.00 48.8K Jul 29, 2021 Common Stock 48.8K $8.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal monthly installments over 36 months measured from July 29, 2021 subject to Reporting Person's continuous service status as of each such date.